Prana Enrolls First Patient in the “Reach2HD” Phase II Huntington Disease Trial July 17, 2013August 16, 2022
FDA Approval to Commence Huntington’s Disease Clinical Trial Using Prana’s PBT2: Huntington Study Group appointed to coordinate the trial and start recruitment July 17, 2013August 16, 2022
